Loss-of-function siRNA interference experiments consisting of 189 treated versus 179 control HCT116 samples showed that the silencing of HOXB9 markedly suppressed CRC cell proliferation over five days post gene expression modulation (p < 0.001) (Figure 3d,e). This evidence concerns the gene HOXB9 and colorectal carcinoma.